ClinicalTrials.Veeva

Menu

Respiratory Proprioceptive Neuromuscular Facilitation Technique in Chronic Pulmonary Obstructive Disease Patients. (COPD)

R

Riphah International University

Status

Completed

Conditions

COPD

Treatments

Other: PNF
Other: Conventional

Study type

Interventional

Funder types

Other

Identifiers

NCT05876403
Maira Tamkeen

Details and patient eligibility

About

The purpose of this study is to evaluate the impact of PNF technique combined with aerobic exercises among COPD patients in a clinical setting. Previous literature has evaluated this technique in ventilated patients but in clinical setting specifically in Pakistan, this invention therapy has not been implied in COPD patients.

Full description

Chronic Obstructive Pulmonary Disorder manifested as breathlessness, respiratory difficulties and persistent cough is one of the biggest causes of mortality around the world. 2.1% of Pakistani population has COPD. Proprioceptive neuromuscular facilitation is used as management technique in which muscle stretching promotes chest wall mobility and restores regular breathing rhythm. In previous studies, PNF technique combined with aerobic exercises has been utilized to improve Pulmonary functions in COPD patients. But the sample size of these studies was small and participants were ventilated patients, hence not targeting the diaphragm. Our study shall evaluate the impact of PNF technique combined with aerobic training on the Pulmonary function of COPD patients in the clinical setting.

Enrollment

56 patients

Sex

All

Ages

35 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Both male & female participants.
  • Diagnosed COPD patients
  • Age 35-60years
  • Ratio of forced expiratory volume in first second & forced vital capacity(FEV1/FVC <0.7,30%<FEV1<80%
  • Stable clinical condition.

Exclusion criteria

  • Serious conditions with require supplementary oxygen or ventilator/support devices.
  • COPD exacerbation within last 4weeks
  • Patients with recent chest wall trauma, surgery or deformity.
  • Patient with neurological, psychological, musculoskeletal, or cardiac medical history.
  • Pulmonary disease with physical impairment.
  • Inability to follow the pulmonary rehabilitation program.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

56 participants in 2 patient groups

Conventional
Active Comparator group
Description:
The protocol for controlled group will consist of 35-60years old participants with moderate to severe COPD. At baseline measurements will be collected and COPD assessment test (CAT) and Modified Borg Scale will be taken. Participants will then be made to perform breathing and aerobic exercises (3sessions per week) for 6 weeks and after every 2 weeks outcome measures will be evaluated using chest expansion, spirometry, and 6 minutes walk test (6MWT) along with CAT and Modified Borg Scale.
Treatment:
Other: Conventional
PNF Techniques
Experimental group
Description:
The same protocol will be followed for the 30 participants of experimental group where after the baseline measurements, participants will perform breathing and aerobic exercises along with PNF techniques (3 sessions per week for 6 weeks). The outcome Measures will be measured after every 2 weeks through Spirometry, CAT, Modified Borg Dyspnea Scale and 6 minutes walk test
Treatment:
Other: PNF

Trial contacts and locations

1

Loading...

Central trial contact

Suman Sheraz, PhD*

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems